Instrumento Inactivo

Otros idiomas UMN Pharma Inc.

Acciones

4585

JP3944320005

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

AIM ImmunoTech Inc. Enters into Mutual Confidentiality Agreement with UMN Pharma Inc., Japan National Institute of Infectious Diseases, and Shionogi & Co., Ltd	27/04/20
Shionogi & Co., Ltd. completed the acquisition of 52.74% stake in UMN Pharma Inc. for ¥5 billion.	12/12/19
Shionogi & Co., Ltd. made a tender offer to acquire 69.6% stake in UMN Pharma Inc for approximately ¥6.7 billion.	30/10/19
UMN Pharma Inc. Reports Non-Consolidated Earnings Results for the Six Months Ended June 30, 2019; Provides Earnings Guidance for the Fiscal Year Ending December 31, 2019	31/07/19
UMN Pharma Inc. Reports Non-Consolidated Earnings Results for the Quarter Ended March 31, 2018; Provides Earnings Guidance for the Fiscal Year Ending December 31, 2018	27/04/18
UMN Pharma Inc. Announces Non Consolidated Earnings Results for the Year Ended December 31, 2017; Provides Earnings Guidance for the Full Year of 2018	14/02/18
UMN Pharma Inc. announced that it has received ¥1.639 billion in funding from Shionogi & Co., Ltd.	16/11/17
UMN Pharma Inc. announced that it expects to receive ¥1.64 billion in funding from Shionogi & Co., Ltd.	31/10/17
Umn Pharma Inc. Announces Non-Consolidated Earnings Results for the Nine Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending December. 31, 2017	31/10/17
UMN Pharma Inc.(TSE:4585) dropped from S&P Global BMI Index	18/09/17
UMN Pharma Inc. Announces Nonconsolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Nonconsolidated Earnings Guidance for the Year Ending December 31, 2017	31/07/17
Umn Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2017; Provide Earnings Guidance for the Year 2017	28/04/17
UMN Pharma Inc. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended December 31, 2016; Provides Earnings Guidance for the Year Ending December 31, 2017	14/02/17
API Co., Ltd. acquired 50% stake in Unigen KK from UMN Pharma Inc..	31/01/17
Umn Pharma Inc. Announces Consolidated Earnings Results for the First Nine Months Ended September 30, 2016; Provides Earnings Guidance for the Year Ending March 31, 2016	31/10/16
UMN Pharma Inc. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2016; Provides Earnings Guidance for the Year Ending December 31, 2016	29/07/16
UMN Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2016	28/04/16
UMN Pharma Inc. Announces Consolidated and Non-Consolidated Earnings Results for the Year Ended December 31, 2015	12/02/16
UMN Pharma Inc. Announces Consolidated Earnings Results for the First Nine Month Ended September 30, 2015; Updates Consolidated Earnings Guidance for the Year Ending March 31, 2016	30/10/15
UMN Pharma Inc. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2015; Revises Earnings Guidance for the Year Ending December 31, 2015	31/07/15

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas UMN Pharma Inc.

Acciones

4585

JP3944320005

Otros idiomas

Filtros